FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4383760329> ?p ?o ?g. }

• W4383760329 endingPage "e0286947" @default.
• W4383760329 startingPage "e0286947" @default.
• W4383760329 abstract "Objective Breakthrough cancer pain should be properly assessed for better-personalized treatment plan. The Breakthrough Pain Assessment Tool is a 14-item tool validated in English developed for this purpose; no French version is currently available and validated. This study aimed to translate it in French and assess the psychometric properties of a French version of the Breakthrough Pain Assessment Tool (BAT-FR). Methods First, translation and cross-cultural adaptation of the 14 items (9 ordinal and 5 nominal) of the original BAT tool in French language was made. Second, assessments of validity (convergent, divergent and discriminant validity), factorial structure (exploratory factor analysis) and test-retest reliability of the 9 ordinal items were done with data of 130 adult cancer patients suffering from breakthrough pain in a hospital-academic palliative care center. Test-retest reliability and responsiveness of total and dimension scores derived from these 9 items were also assessed. Acceptability of the 14 items was also assessed on the 130 patients. Results The 14 items had good content and face validity. Convergent and divergent validity, discriminant validity and test-retest reliability of the ordinal items were acceptable. Test-retest reliability and responsiveness of total and dimensions derived from ordinal items were also acceptable. The factorial structure of the ordinal items had two dimensions similar to the original version: “1—pain severity and impact” and “2—pain duration and medication”. Items 2 and 8 had a low contribution to the dimension 1 they were assigned and item 14 clearly changed of dimension compared with the original tool. The acceptability of the 14 items was good. Conclusion The BAT-FR has shown acceptable validity, reliability and responsiveness supporting its use for assessing breakthrough cancer pain in French-speaking populations. Its structure needs nevertheless further confirmation." @default.
• W4383760329 created "2023-07-11" @default.
• W4383760329 creator A5029961898 @default.
• W4383760329 creator A5031736363 @default.
• W4383760329 creator A5033780979 @default.
• W4383760329 creator A5034245689 @default.
• W4383760329 creator A5043854020 @default.
• W4383760329 creator A5053882454 @default.
• W4383760329 creator A5076752506 @default.
• W4383760329 creator A5080792919 @default.
• W4383760329 creator A5084227816 @default.
• W4383760329 date "2023-07-10" @default.
• W4383760329 modified "2023-10-16" @default.
• W4383760329 title "Validation of a French version of the Breakthrough Pain Assessment Tool in cancer patients: Factorial structure, reliability and responsiveness" @default.
• W4383760329 cites W1972842876 @default.
• W4383760329 cites W1982025877 @default.
• W4383760329 cites W1987318150 @default.
• W4383760329 cites W1990596188 @default.
• W4383760329 cites W1992193527 @default.
• W4383760329 cites W1997268860 @default.
• W4383760329 cites W2011309176 @default.
• W4383760329 cites W2023183852 @default.
• W4383760329 cites W2024587010 @default.
• W4383760329 cites W2032154703 @default.
• W4383760329 cites W2040890982 @default.
• W4383760329 cites W2041404177 @default.
• W4383760329 cites W2051576146 @default.
• W4383760329 cites W2056558582 @default.
• W4383760329 cites W2067903446 @default.
• W4383760329 cites W2071666535 @default.
• W4383760329 cites W2076668534 @default.
• W4383760329 cites W2077139817 @default.
• W4383760329 cites W2114256414 @default.
• W4383760329 cites W2133012565 @default.
• W4383760329 cites W2149914631 @default.
• W4383760329 cites W2153190882 @default.
• W4383760329 cites W2157427387 @default.
• W4383760329 cites W2164777277 @default.
• W4383760329 cites W2168257019 @default.
• W4383760329 cites W2178150327 @default.
• W4383760329 cites W2265158039 @default.
• W4383760329 cites W2320909684 @default.
• W4383760329 cites W2333098787 @default.
• W4383760329 cites W2337210803 @default.
• W4383760329 cites W2480133395 @default.
• W4383760329 cites W2734610390 @default.
• W4383760329 cites W2919501482 @default.
• W4383760329 cites W2997864015 @default.
• W4383760329 cites W4240787498 @default.
• W4383760329 doi "https://doi.org/10.1371/journal.pone.0286947" @default.
• W4383760329 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37428747" @default.
• W4383760329 hasPublicationYear "2023" @default.
• W4383760329 type Work @default.
• W4383760329 citedByCount "1" @default.
• W4383760329 crossrefType "journal-article" @default.
• W4383760329 hasAuthorship W4383760329A5029961898 @default.
• W4383760329 hasAuthorship W4383760329A5031736363 @default.
• W4383760329 hasAuthorship W4383760329A5033780979 @default.
• W4383760329 hasAuthorship W4383760329A5034245689 @default.
• W4383760329 hasAuthorship W4383760329A5043854020 @default.
• W4383760329 hasAuthorship W4383760329A5053882454 @default.
• W4383760329 hasAuthorship W4383760329A5076752506 @default.
• W4383760329 hasAuthorship W4383760329A5080792919 @default.
• W4383760329 hasAuthorship W4383760329A5084227816 @default.
• W4383760329 hasBestOaLocation W43837603291 @default.
• W4383760329 hasConcept C120107772 @default.
• W4383760329 hasConcept C121244757 @default.
• W4383760329 hasConcept C121332964 @default.
• W4383760329 hasConcept C151730666 @default.
• W4383760329 hasConcept C15744967 @default.
• W4383760329 hasConcept C163258240 @default.
• W4383760329 hasConcept C165957694 @default.
• W4383760329 hasConcept C171606756 @default.
• W4383760329 hasConcept C1862650 @default.
• W4383760329 hasConcept C2777267654 @default.
• W4383760329 hasConcept C3018868096 @default.
• W4383760329 hasConcept C43214815 @default.
• W4383760329 hasConcept C62520636 @default.
• W4383760329 hasConcept C70410870 @default.
• W4383760329 hasConcept C71924100 @default.
• W4383760329 hasConcept C86803240 @default.
• W4383760329 hasConceptScore W4383760329C120107772 @default.
• W4383760329 hasConceptScore W4383760329C121244757 @default.
• W4383760329 hasConceptScore W4383760329C121332964 @default.
• W4383760329 hasConceptScore W4383760329C151730666 @default.
• W4383760329 hasConceptScore W4383760329C15744967 @default.
• W4383760329 hasConceptScore W4383760329C163258240 @default.
• W4383760329 hasConceptScore W4383760329C165957694 @default.
• W4383760329 hasConceptScore W4383760329C171606756 @default.
• W4383760329 hasConceptScore W4383760329C1862650 @default.
• W4383760329 hasConceptScore W4383760329C2777267654 @default.
• W4383760329 hasConceptScore W4383760329C3018868096 @default.
• W4383760329 hasConceptScore W4383760329C43214815 @default.
• W4383760329 hasConceptScore W4383760329C62520636 @default.
• W4383760329 hasConceptScore W4383760329C70410870 @default.
• W4383760329 hasConceptScore W4383760329C71924100 @default.
• W4383760329 hasConceptScore W4383760329C86803240 @default.
• W4383760329 hasFunder F4320323878 @default.

• next